1Resnic FS. Vascular devices and the risk of vascular complications after percutaneous coronary intervention in patients receiving glycoprotein Ⅱb/Ⅲa inhibitors. Am J Cardiol, 2001,88:493-506. 被引量：1
3Sesana M, Baghetti M, Albiero R, et al. Effectiveness and complications of vascular access closure devices after interventional procedures. J Invas Cardiol, 2000,12:395-399. 被引量：1
4Dangas G. Vascular complications after percutaneous coronary interventions following hemostasis with manual compression versus arteriotomy closure devices. J Am Coll Cardiol, 2001,52:3-7. 被引量：1
5Cura FA, Kapadia SR, L'Allier PL, et al. Safety of femoral closure devices after percutaneous coronary interventions in the era of glycoprotein Ⅱb/Ⅲa platelet blockade. Am J Cardiol, 2000,86:780-782. 被引量：1
二级参考文献4
1Resnic FS. Vascular devices and the risk of vascular complications after percutaneous coronary intervention in patients receiving glycoprotein Ⅱb/Ⅲ a inhibitors. Am J Cardiol, 2001,88:493-506. 被引量：1
2Sesana M, Baghetti M, Albiero R, et al. Effectiveness and complications of vascular access closure devices after interventional procedures. J Invas Cardiol, 2000, 12: 395-399. 被引量：1
3Dangas G. Vascular complications after percutaneous coronary interventions following hemostasis with manual compression versus arteriotomy closure devices. J Am Coll Cardiol, 2001,52:3-7. 被引量：1
4Cura EA, Kapadia SR, Allier PL, et al. Safety of femoral closure devices after percutaneous coronary interventions in the era of glycoprotein Ⅱ b/Ⅲa platelet blockade. Am J Cardiol, 2000,86:780-782. 被引量：1
9Resnic FS,Blake GJ,Ohno-Machadol,et al.Vascular closure devices and the risk of vascular complications after percutaneous coronary intervention in patients receiving glycoprotein Ⅱb-Ⅲa Inhibitors[J].Am J Cardiol,2001,88:493-496. 被引量：1
10Meyerson SL,Feldman T,Desai TR,et al.Angiographic access site complications in the era of arterial closure devices[J].Vasc Endovascular Surg,2002,36:137-144. 被引量：1
